Atrás
También listada como
SDMHF
OTC
Rango del Día
$18.47
$20.20
Rango de 52 Semanas
$17.40
$26.54
Volumen
1,350
Promedio 50D / 200D
$22.02
/
$22.46
Cierre Anterior
$18.93
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 742.1 | 0.4 |
| P/B | 46.3 | 2.9 |
| ROE % | 6.3 | 3.8 |
| Net Margin % | 9.0 | 3.9 |
| Rev Growth 5Y % | -0.3 | 10.0 |
| D/E | 0.7 | 0.2 |
Puntos Clave
Revenue declined -0.32% annually over 5 years
Earnings grew 45.70% over the past year
Generating 139.66M in free cash flow
P/E of 742.10 — premium valuation
Crecimiento
Revenue Growth (5Y)
-0.32%
Revenue (1Y)2.53%
Earnings (1Y)45.70%
FCF Growth (3Y)-28.45%
Calidad
Return on Equity
6.32%
ROIC5.78%
Net Margin8.95%
Op. Margin18.50%
Seguridad
Debt / Equity
0.67
Current Ratio1.02
Interest Coverage3.60
Valoración
P/E Ratio
742.10
P/B Ratio46.30
EV/EBITDA363.43
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.53% | Revenue Growth (3Y) | 1.34% |
| Earnings Growth (1Y) | 45.70% | Earnings Growth (3Y) | -9.24% |
| Revenue Growth (5Y) | -0.32% | Earnings Growth (5Y) | -11.42% |
| Profitability | |||
| Revenue (TTM) | 2.85B | Net Income (TTM) | 255.12M |
| ROE | 6.32% | ROA | 3.18% |
| Gross Margin | 45.33% | Operating Margin | 18.50% |
| Net Margin | 8.95% | Free Cash Flow (TTM) | 139.66M |
| ROIC | 5.78% | FCF Growth (3Y) | -28.45% |
| Safety | |||
| Debt / Equity | 0.67 | Current Ratio | 1.02 |
| Interest Coverage | 3.60 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 742.10 | P/B Ratio | 46.30 |
| P/S Ratio | 66.42 | PEG Ratio | -9.01 |
| EV/EBITDA | 363.43 | Dividend Yield | 0.00% |
| Market Cap | 189.32B | Enterprise Value | 191.65B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.85B | 2.78B | 2.78B | 3.49B | 2.89B |
| Net Income | 255.12M | 175.10M | 309.70M | 876.10M | 414.40M |
| EPS (Diluted) | 0.03 | 0.18 | 0.34 | 0.95 | 0.45 |
| Gross Profit | 1.29B | 1.21B | 1.23B | 1.82B | 1.55B |
| Operating Income | 527.33M | 370.60M | 484.50M | 1.08B | 683.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8.01B | 8.26B | 7.74B | 5.07B | 3.95B |
| Total Liabilities | 3.89B | 4.23B | 5.07B | 2.55B | 2.22B |
| Shareholders' Equity | 4.09B | 3.99B | 2.64B | 2.45B | 1.66B |
| Total Debt | 2.75B | 2.87B | 3.68B | 1.14B | 625.52M |
| Cash & Equivalents | 425.92M | 678.90M | 116.60M | 107.10M | 223.63M |
| Current Assets | 1.44B | 1.74B | 1.42B | 1.67B | 1.46B |
| Current Liabilities | 1.41B | 938.80M | 937.30M | 1.04B | 1.04B |